Health-system pharmacists who compound medications just for their own patients are accustomed to periodic inspections by state boards of pharmacy, the Joint Commission or other groups. But some pharmacies have found themselves under scrutiny in the past year or so by a more powerful regulator: the FDA.
“The whole idea that FDA is inspecting hospital pharmacies is very new,” said Robert MacArthur, PharmD, the pharmacy director for the Rockefeller University Hospital, in